ArticleJournal of cancer research and clinical oncology2019

Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.

Jihao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.